Back to User profile » Dr Michael Jain
Paper published by Dr Michael Jain:
Review
Axicabtagene ciloleucel (KTE-C19), an anti-CD19 CAR T therapy for the treatment of relapsed/refractory aggressive B-cell non-Hodgkin’s lymphoma
Jain MD, Bachmeier CA, Phuoc VH, Chavez JC
Therapeutics and Clinical Risk Management 2018, 14:1007-1017
Published Date: 31 May 2018